103 related articles for article (PubMed ID: 3338872)
1. Macrophages associated with murine tumours express plasminogen activator activity.
Mussoni L; Riganti M; Acero R; Erroi A; Conforti G; Mantovani A; Donati MB
Int J Cancer; 1988 Feb; 41(2):227-30. PubMed ID: 3338872
[TBL] [Abstract][Full Text] [Related]
2. Procoagulant activity of macrophages associated with different murine neoplasms.
Guarini A; Acero R; Alessio G; Donati MB; Semeraro N; Mantovani A
Int J Cancer; 1984 Oct; 34(4):581-6. PubMed ID: 6386701
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma.
Eisenbach L; Segal S; Feldman M
J Natl Cancer Inst; 1985 Jan; 74(1):77-85. PubMed ID: 3855489
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator activity of metastatic variants from a murine fibrosarcoma; effect of thrombin in vitro.
Coen D; Bottazzi B; Bini A; Conforti MG; Mantovani A; Mussoni L; Donati MB
Int J Cancer; 1983 Jul; 32(1):67-70. PubMed ID: 6683249
[TBL] [Abstract][Full Text] [Related]
5. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.
Chapman HA; Stone OL; Vavrin Z
J Clin Invest; 1984 Mar; 73(3):806-15. PubMed ID: 6368589
[TBL] [Abstract][Full Text] [Related]
6. Expression of plasminogen activator as a marker of stimulation in tumor-associated macrophages.
Mussoni L; Donati MB
Haemostasis; 1988; 18(1):66-71. PubMed ID: 3047025
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
[TBL] [Abstract][Full Text] [Related]
8. Macrophage cell lines behave as activated macrophages in the production and regulation of plasminogen activator.
Jones CM; Goldfarb RH; Holden HT
Cancer Invest; 1983; 1(3):207-13. PubMed ID: 6686788
[TBL] [Abstract][Full Text] [Related]
9. Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.
Dong Q; Zhou MH; Subbarao V; Ts'ao CH
Br J Exp Pathol; 1988 Oct; 69(5):685-95. PubMed ID: 3143395
[TBL] [Abstract][Full Text] [Related]
10. Secretion of plasminogen activator by bone marrow-derived mononuclear phagocytes and its enhancement by colony-stimulating factor.
Lin HS; Gordon S
J Exp Med; 1979 Aug; 150(2):231-45. PubMed ID: 313429
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
Jiao J; Yu M; Ru B
Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator activity of cultured murine macrophages and effects of isopropylmethylphosphonofluoridate (sarin).
Dubois P; Lison D; Lauwerys R
Biochem Pharmacol; 1988 Jun; 37(11):2139-43. PubMed ID: 3132170
[TBL] [Abstract][Full Text] [Related]
13. The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.
Cook AD; Vlahos R; Massa CM; Braine EL; Lenzo JC; Turner AL; Way KJ; Hamilton JA
Thromb Haemost; 2006 Apr; 95(4):659-67. PubMed ID: 16601837
[TBL] [Abstract][Full Text] [Related]
14. Ia antigen expression and IL-1 activity in murine tumour-associated macrophages.
Peri G; Rossi V; Taraboletti G; Erroi A; Mantovani A
Immunology; 1986 Dec; 59(4):527-33. PubMed ID: 3492438
[TBL] [Abstract][Full Text] [Related]
15. In situ effector pathways of allograft destruction. 3. Plasminogen activator activity in rat renal allografts.
Alföldy P; Lindroos H; Soots A; Nemlander A; Häyry P
Cell Immunol; 1984 Sep; 87(2):580-90. PubMed ID: 6380768
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the neutral protease activity of macrophages treated with asbestos in vitro.
Hamilton JA
Environ Health Perspect; 1983 Sep; 51():103-8. PubMed ID: 6416822
[TBL] [Abstract][Full Text] [Related]
17. Factors involved in the plasminogen activation system in human breast tumours.
Damjanovich L; Turzó C; Adány R
Thromb Haemost; 1994 Jun; 71(6):684-91. PubMed ID: 7974332
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the plasminogen activation system in murine macrophages.
Kung SK; Lau HK
Biochim Biophys Acta; 1993 Mar; 1176(1-2):113-22. PubMed ID: 8452867
[TBL] [Abstract][Full Text] [Related]
19. Bacille Calmette-Guérin infection in the mouse. Regulation of macrophage plasminogen activator by T lymphocytes and specific antigen.
Gordon S; Cohn ZA
J Exp Med; 1978 Apr; 147(4):1175-88. PubMed ID: 349108
[TBL] [Abstract][Full Text] [Related]
20. Mouse tumor-associated macrophages do not generate procoagulant activity in response to different stimuli.
Erroi A; Casali B; Donati MB; Mantovani A; Semeraro N
Int J Cancer; 1988 Jan; 41(1):65-8. PubMed ID: 3275591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
